Healthcare Pharmaceutical Biotech

Study Finds Healthcare Concern Jumps From 31% to 74% After Federal Debt Connection Is Explained

September 15, 2026 7:50 AM

Black Book Research today announced the publication of "The $40 Trillion Healthcare Question: National Healthcare Consumer Awareness, Expectations & Household Resilience Study," examining how Americans understand and believe they would experience the healthcare consequences of sustained federal fiscal pressure. The Q3 2026 study reports online and panel findings from 1,500 U.S. adults age 18 and older in Q3. The study identifies a substantial...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026

September 14, 2026 5:20 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.3 million and $7.3 million, respectively, representing increases of approximately $0.4 million and $0.5 million compared to the same periods last year. For the three and nine months ended July...

Read more

Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

September 14, 2026 3:59 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has engaged Prime Ledger Inc. ("Prime Ledger"), a digital asset advisory and tokenization firm, to structure a tokenized financing backed by the Company's intellectual property in CCX0722, an ingestible hydrogel-based medical device in development for weight management. Prime Ledger will serve...

Read more

Amid Growing Physician Shortages, Desert Oasis Healthcare Expands Access to Local Care

September 14, 2026 12:50 PM

For more than four decades, Desert Oasis Healthcare (DOHC) has been committed to providing high-quality, coordinated healthcare close to home for people throughout the Coachella Valley and surrounding communities. Today, more than 60,000 members and patients rely on DOHC for care, with access to a broad network of primary care physicians, specialists and healthcare services across the region. The need for local access to physicians is especially...

Read more

AGFA HealthCare Puts Clinical Attention at the Center of Enterprise Imaging at RSNA 2026

September 14, 2026 10:30 AM

"Clinical attention has become one of healthcare's most valuable resources. The technology surrounding clinicians should preserve focus, not compete for it," said Nathalie McCaughley, President, AGFA HealthCare. "At RSNA 2026, we're showing how Enterprise Imaging continues to evolve around one consistent clinical experience. By bringing workflow, intelligence, and information together around how clinicians naturally work, we can reduce friction...

Read more

MDCE Subsidiaries Execute First Fanatics / Topps Transaction: Infinite Auctions Sells, Real Game Used Authenticates (OTCID:MDCE)

September 14, 2026 9:47 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that its wholly owned subsidiaries Infinite Auctions and Real Game Used have entered into a transactional agreement with Fanatics / Topps. Under the agreement, Infinite Auctions will sell game-worn sports memorabilia to Topps for use in Topps sports trading card products. Real Game Used will provide photo-match authentication for the products supplied by Infinite Auctions. Fanatics is...

Read more

DaVita Community Care Report 2025: Empowering Teammates Through Career Development and Education

September 14, 2026 9:40 AM

Sustainable career growth is about unlocking lasting economic mobility and new opportunities to learn and grow as an individual. In an evolving healthcare landscape, DaVita is working to empower teammates through intentional, comprehensive support. By prioritizing career pathways that directly expand earning potential, our end-to-end development pipeline pairs robust financial and educational resources with tailored social support. The result is...

Read more

Dr. Thomas Pane Obtains Hospital Privileges at Holy Cross in Fort Lauderdale

September 14, 2026 9:00 AM

Dr. Thomas Pane, a double board-certified plastic surgeon practicing in Palm Beach Gardens, has obtained hospital privileges at Holy Cross in Fort Lauderdale. The privileges allow him to perform procedures in a hospital setting when a patient's individual circumstances or medical needs make a hospital more appropriate than an office-based surgical facility or an ambulatory surgery center. The privileges add to the settings already available to...

Read more

I Am CVS Health: Chelsey Shaw

September 14, 2026 9:00 AM

Originally published on CVS Health Company Newsroom By Malcolm Bracy Key points Chelsey is a registered nurse with Coram CVS Specialty Infusion Services who has spent 13 years delivering home infusion therapies for patients with rare and genetic diseases. After Chelsey and her husband adopted their son, his medical needs put their family on the receiving end of the kind of care she'd spent her career providing. Home is where people feel safe,...

Read more

When Words Stay Silent: How Sign Language Avatars Are Transforming Access to Medicine

September 14, 2026 8:35 AM

Boehringer Ingelheim When information looks accessible-but isn't At first glance, medicine package inserts appear readable. They are printed, structured, and written in clear paragraphs. But for many deaf people, written medical information can quickly turn into a barrier. "Deaf people can read; they're not blind," is a common assumption among hearing people. But reading does not always equal understanding-especially when the medical text...

Read more

Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

September 14, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced that Richard Langford, Chief Medical Officer of Cy Biopharma, has been selected to present in person at the U.S. Food and Drug Administration's ("FDA") public hearing, "Considerations for...

Read more

Cannabis Attorney Warns State Operators: Marijuana Schedule III May Not Survive Court Review

September 14, 2026 6:00 AM

MMJ International Holdings, Inc., together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), says a new analysis from a prominent cannabis attorney underscores what the marijuana industry may be overlooking following this week's D.C. Circuit ruling: The court denied an emergency stay. It did not decide whether the federal Schedule III order is lawful. And a cannabis attorney is now warning state marijuana...

Read more

Dr. Cory Torgerson of The Toronto Hair Transplant Clinic Introduces Combined FUE, PRP, and Laser Phototherapy Protocol to Preserve Native Hair Density

September 14, 2026 4:20 AM

Hair transplantation for natural results is not only about the placement of grafts into the balding area but also planning in the long run to ensure the safety of the hair around the area receiving the transplant. Whereas surgery relocates the healthy grafts, the non-transplanted hair follicles still remain susceptible to androgenic miniaturization. To treat this long-term physiological problem Dr Cory Torgerson along with The Toronto Hair...

Read more

CMS's Hemp CBD Program Has A Physician Problem - MMJ Appeal Pending

September 12, 2026 11:45 AM

MMJ International Holdings, Inc., together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), says the federal government's cannabinoid experiment on seniors is confronting a basic problem that policy cannot solve: Physicians still have to decide what they are willing to give their patients. The Centers for Medicare & Medicaid Services created the Substance Access Beneficiary Engagement Incentive, or...

Read more

ESA Letter Online: RealESALetter.com Builds Momentum as a Trusted ESA Letter Service for 2027

September 12, 2026 8:30 AM

As demand for online mental health services continues to evolve in 2026, RealESALetter.com is building momentum as an online ESA letter service for U.S. residents seeking access to licensed mental health professionals. The platform connects applicants across all 50 states and D.C. with licensed professionals and reports serving more than 750,000 verified customers. For people researching an ESA letter online, understanding what the document does...

Read more

La Boussole Medical Spa & Wellness Center Adds Tixel 2 to Its Advanced Aesthetic Treatment Offerings

September 11, 2026 2:30 PM

La Boussole Medical Spa & Wellness Center, recognized as one of the Top 10 Medical Spas in the Country, announced the addition of Tixel 2 to its expanding range of cosmetic and skin rejuvenation treatments for clients in Joplin and surrounding communities. Tixel 2 is an FDA-cleared fractional skin resurfacing system that uses proprietary Thermo-Mechanical Action (TMA) technology. Unlike laser or light-based resurfacing systems, Tixel 2 delivers...

Read more

Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units

September 11, 2026 11:10 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has secured a new five-year contract manufacturing agreement with Viofar covering approximately 2.5 million units of ROSARTIA. The agreement represents approximately 500,000 contracted units annually and increases Cana's cumulative...

Read more

Tixel i Receives CE Certification, Expanding Access to TMA(R) Dry Eye Therapy Across Europe

September 11, 2026 10:20 AM

Novoxel® Ltd., developer of Tixel, today announced that Tixel i, its proprietary device for the treatment of dry eye disease, has received CE certification under EU Medical Device Regulation (MDR) certificate 725869, clearing the way for the device to be marketed and sold across the European Union. The certification allows eye care practitioners throughout Europe to offer the Tixel for Dry Eye procedure, a non-invasive, in-office treatment that...

Read more

From Paper to Pixels: How Digitalization in Healthcare Can Benefit Rural Communities

September 11, 2026 9:35 AM

Many remote communities lack access to quality healthcare for various reasons, a major one being the reliance on paper medical records. In Argentina, doctors struggled to keep track of patients' medical records to provide consistent care across vast distances. This compromised the quality of consultations, as records were often incomplete or scattered. Digitalization in healthcare can address these challenges and ensure personal data security....

Read more

Medical Care Technologies (OTCID:MDCE) Advances StrainScan Pro Into a Second Major Vertical: The $4 Trillion Foodservice Market

September 11, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced further progress on StrainScan Pro's foodservice application, advancing the platform from market positioning into a custom demonstration path for commercial kitchens and multi-unit operators. The platform is live at https://strainscanpro.com. Foodservice has already been identified as a core StrainScan Pro vertical alongside agriculture. The Company is now taking the same next step it...

Read more